Due to the inability to obtain all of the necessary clinical data on samples from children with ALL, we compared the results of the quantitative analysis of VEGF-A and FGF-2 only with the concentrations of the same biomarkers in the serum of children without diagnosed cancer or inflammatory lesions. This evidence concerns the gene VEGFA and cancer.